IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 204 filers reported holding IMMUNOGEN INC in Q4 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $32,457,356 | +107.9% | 2,045,202 | +147.2% | 2.05% | +100.1% |
Q2 2023 | $15,611,491 | +111.2% | 827,318 | -57.0% | 1.02% | +116.3% |
Q1 2023 | $7,390,203 | -11.6% | 1,924,532 | +14.1% | 0.47% | -4.6% |
Q4 2022 | $8,363,324 | +248.3% | 1,686,154 | +235.6% | 0.50% | +254.3% |
Q3 2022 | $2,401,000 | -53.2% | 502,393 | -56.0% | 0.14% | -67.3% |
Q2 2022 | $5,134,000 | -24.5% | 1,140,788 | -20.1% | 0.43% | -17.1% |
Q1 2022 | $6,798,000 | -47.6% | 1,428,169 | -18.4% | 0.52% | -31.9% |
Q4 2021 | $12,984,000 | +3098.0% | 1,749,882 | +1066.6% | 0.76% | +1843.6% |
Q1 2019 | $406,000 | -81.1% | 150,000 | -66.4% | 0.04% | -85.4% |
Q4 2018 | $2,146,000 | – | 447,075 | – | 0.27% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 17,503,417 | $277,779,228 | 13.22% |
Fairmount Funds Management LLC | 5,929,592 | $94,102,625 | 11.32% |
CM Management, LLC | 500,000 | $7,935,000 | 8.42% |
SILVERARC CAPITAL MANAGEMENT, LLC | 1,307,435 | $20,748,993 | 6.29% |
Altium Capital Management LP | 725,000 | $11,505,750 | 6.00% |
RA Capital Management | 13,322,288 | $211,424,711 | 4.16% |
TANG CAPITAL MANAGEMENT LLC | 1,500,000 | $23,805,000 | 3.36% |
BRIDGER MANAGEMENT, LLC | 467,220 | $7,414,781 | 2.73% |
Birchview Capital, LP | 190,000 | $3,015,300 | 2.57% |
Boxer Capital, LLC | 2,961,000 | $46,991,070 | 2.50% |